Moses Donkor

Moses Donkor is currently serving as the Director of Translational Medicine at AstraZeneca since February 2024. Prior to this role, Donkor was the Associate Director at BioXcel Therapeutics, Inc., where leadership in Precision Medicine for biomarker discovery and strategic initiatives was a key focus from December 2021 to February 2024. Earlier experience includes positions at Incyte as a Senior Research Investigator, leading immune-oncology discovery programs, and at MedImmune as a Scientist, where early drug discovery programs for cancer vaccines were developed. Donkor also held a Postdoctoral Fellow position at The University of Texas at Austin, focusing on immunosuppression in cancer treatment, and contributed to cancer research as a Graduate Student at Weill Cornell Graduate School of Medical Sciences. Educational credentials include a PhD in Immunology from Weill Cornell, a Master's in Biology from the University of Nebraska at Omaha, and a Bachelor's in Biochemistry from the University of Ghana.